Search
May 16, 2024
Biotheryx's CEO on the company's protein degradation platform and CDK4/6 program that is IND cleared and will be entering the clinic
Leah Fung describes how Biotheryx is leveraging the E3 ligase Cereblon to enable its protein degradation, and discusses the lead CD4/6...